Biomarkers in Neurodegenerative Diseases

Stopped Lack of regulatory approval

Conditions

• Mild Cognitive Impairment (MCI)
• Alzheimer Disease (AD)
• Dementia With Lewy Bodies (DLB)
• Frontotemporal Lobar Degeneration (FTLD)
• Parkinsons Disease With Dementia (PDD)
• Transient Epileptic Amnesia (TEA)
• Temporal Lobe Epilepsy (TLE)
• Spinocerebellar Ataxias (SCA)
• HIV Associated Neurocognitive Disorder (HAND)
• Amyotrophic Lateral Sclerosis (ALS)
• Primary Lateral Sclerosis (PLS)

Interventions

• OTHER: Neuraceq

Sponsor

University of Minnesota